...
首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Mesalazine granules 1.5?g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
【24h】

Mesalazine granules 1.5?g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials

机译:服用其他5-ASA制剂的溃疡性结肠炎患者每天服用1.5 mg的美沙拉嗪颗粒可缓解症状:来自两项随机对照试验的汇总分析

获取原文
获取原文并翻译 | 示例

摘要

Mesalazine (mesalamine) granules (MG) were shown to be effective for the maintenance of remission of ulcerative colitis (UC) in two double-blind placebo-controlled trials.
机译:在两项双盲安慰剂对照试验中,美沙拉嗪(美沙拉敏)颗粒(MG)可以有效维持溃疡性结肠炎(UC)的缓解。

著录项

  • 来源
    《Alimentary Pharmacology & Therapeutics 》 |2012年第2期| 126-134| 共9页
  • 作者单位

    Gastroenterology Division Department of Medicine University of Pennsylvania Philadelphia PA USA;

    Connecticut Gastroenterology Institute Bristol CT USA;

    Center for Digestive and Liver Diseases Mexico MO USA;

    Syracuse VA Medical Center Syracuse NY USA;

    Gastroenterology Associates of Central Georgia LLC Macon GA USA;

    Nashville Medical Research Institute and The Maria Nathanson Center at Saint Thomas Hospital Nashville TN USA;

    Salix Pharmaceuticals Inc. Raleigh NC USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号